Frequency News and Research

RSS

Economic impact of migraine headaches on American businesses is staggering

With more than 28 million Americans suffering from debilitating migraine headaches each year, employers also suffer through missed days from work and reduced productivity.

30 Dec 2004

High levels of a blood protein called mannose-binding lectin associated with lower risk of heart attack

High levels of a blood protein called mannose-binding lectin (MBL) are associated with lower risk of heart attack, particularly among diabetics, report Saevardottir and colleagues.

28 Dec 2004

Wireless technology does not affect pacemakers and defibrillators

With the dynamic evolution of wireless technology, Mayo Clinic researchers have been concerned about the potential effects of electromagnetic interference on heart pacemakers and implantable cardioverter-defibrillators.

22 Dec 2004

FDA approves Enablex for the treatment of overactive bladder

Novartis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Enablex® (darifenacin) extended-release tablets (7.5mg and 15mg) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency.

22 Dec 2004

Size of myocardial infarct measured using MRI

In animal studies, researchers at Johns Hopkins have effectively used magnetic resonance imaging (MRI) to measure with 94 percent accuracy the size and amount of heart muscle damaged by a heart attack, known in medical terms as a myocardial infarct, or m.i., for short.

20 Dec 2004

Model simulates dynamics of heart rhythm disorders

Dutch researcher Kirsten ten Tusscher has developed a model that can simulate the electrical behaviour of the heart during heart rhythm disorders. One of the things her model revealed is that the electrical activity of the heart during a rhythm disorder is much less chaotic than was originally thought.

20 Dec 2004

Detrol LA significantly reduces symptoms of overactive bladder

Pfizer today announced results of a comprehensive six-year review of efficacy and safety data for Detrol LA (tolterodine tartrate extended release capsules) indicating that Detrol LA significantly reduces symptoms of overactive bladder (OAB) with a low occurrence of side effects, and should be considered first-line therapy.

13 Dec 2004

Notebook computers can have a negative effect on male fertility

US fertility experts are warning teenage boys and young men to consider limiting the time that they use notebook computers positioned on their laps, as long-term use may affect their fertility.

13 Dec 2004

Discovery of key immune system molecules that helps determine how effectively a person resists HIV infection

A team of researchers based partly in South Africa has identified a key set of immune system molecules that helps determine how effectively a person resists infection with human immunodeficiency virus (HIV).

8 Dec 2004

Cardiovascular experts issue blueprint for safer X-Ray imaging

Millions of invasive cardiovascular procedures that involve the use of potentially hazardous X-rays are done in the United States each year.

8 Dec 2004

Physically fit men visit their doctors less frequently

Physically fit men had fewer overnight hospital stays and visited their doctors less frequently, according to the results of a long-term study published this month in Medicine & Science in Sports & Exercise, the official scientific journal of the American College of Sports Medicine (ACSM).

7 Dec 2004

New advances in sickle cell disease

Excruciating pain episodes, recurrent pneumonias, strokes, severe infections, chronic hemolytic anemia, and secondary pulmonary hypertension are common complications of sickle cell disease, a life-threatening inherited defect in blood that causes normally disc-shaped red blood cells to take on a sickle shape.

6 Dec 2004

Sexologist unveils a formula for a better sex life

After centuries of human sexual relations, a leading expert today unveiled the 'Sexual Quotient' (SQ), a formula to help couples assess and improve their sex lives.

6 Dec 2004

As mobile phone use rises, possibility of unseen biological impact is quietly troubling

Cell biologists are of two minds about the possible biological effects of mobile phone radiation. In the mid-1990s, studies describing possible pathological effects on tissues bombarded with low-level radio frequencies (RF) were first featured in the popular press and then discredited by scientists.

4 Dec 2004

Phase 3 results of Genasense plus Dexamethasone in patients with advanced multiple myeloma

Genta Incorporated announced that results from the Company's randomized Phase 3 clinical trial of Genasense(R) (oblimersen sodium) Injection in patients with relapsed or refractory multiple myeloma were presented today at the annual meeting of the American Society of Hematology (ASH) in San Diego, CA.

4 Dec 2004

Study focused on patients with chemotherapy-related anemia

Findings from an interim analysis of a new study comparing the hemoglobin response rates of Epoetin alfa and darbepoetin alfa in the treatment of chemotherapy-related anemia were published in the November 15, 2004 issue of the Medical Journal 'Blood' as part of the American Society of Hematology 46th Annual Meeting and Exposition.

4 Dec 2004